Bionoxx is an innovative biotechnology company pioneering neutrophil-directed T cell modulation to fight cancer and immune disorders. Our team of experts is dedicated to tailoring immunotherapies based on a novel analytical method, to improve clinical outcome for patients. Follow us for groundbreaking advancements and industry collaborations.
Company Details
- Employees
- 12
- Founded
- 2016
- Address
- Seoul
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- immunotherapy, immuno-oncology, gene and cell therapy, viral sepsis, neutrophil-directed modulation, T cell modulation.
- HQ
- Seoul
Bionoxx Questions
Bionoxx's LinkedIn profile is https://kr.linkedin.com/company/bionoxx
Bionoxx has
12 employees.
View email and phone details for 12
employees at Bionoxx.
Bionoxx's industry is
Pharmaceutical Manufacturing
Bionoxx's categories are Pharmaceutical Manufacturing
Bionoxx's founding year is 2016
